ROSIGLITAZONE, A PPAR-GAMMA AGONIST, DOES NOT ALTER THE PHARMACOKINETICS OF NIFEDIPINE, A CYTOCHROME-P450 3A4-SUBSTRATE

Authors
FREED MI MILLER AK INGLIS AM THOMPSON KA LADLEY D JORKASKY DK
Citation
Mi. Freed et al., ROSIGLITAZONE, A PPAR-GAMMA AGONIST, DOES NOT ALTER THE PHARMACOKINETICS OF NIFEDIPINE, A CYTOCHROME-P450 3A4-SUBSTRATE, Diabetes, 47, 1998, pp. 368-368
Citations number
NO
Categorie Soggetti
Endocrynology & Metabolism
Journal title
Diabetes → ACNP
ISSN journal
00121797
Volume
47
Year of publication
1998
Supplement
1
Pages
368 - 368
Database
ISI
SICI code
0012-1797(1998)47:<368:RAPADN>2.0.ZU;2-9